AllStar® Connect wins 2021 GOOD DESIGN® award

We are delighted to announce that DCA and Sanofi have been awarded the renowned GOOD DESIGN® Award for 2021 for the AllStar® Connect device.

AllStar® Connect is an innovative ‘connected’ variable dose injection pen for insulin treatments.

AllStar® Connect helps the treatment of diabetes by automatically recording the details of every insulin dose delivered. Dose records are automatically transferred wirelessly to the patient’s smartphone, where they can be logged and reviewed. These error-free records can help patients and their clinicians to assess how well they are managing diabetes and to make better healthcare decisions.

Paul Draper, Senior Sector Manager at DCA said, “From the start, our central goal was to achieve a design that integrates accurate and reliable dose capturing and communications technologies into a state-of-the-art pen injector, without compromising its size or usability. My congratulations go to the whole multidisciplinary team for the hard work that has made this possible and which has been recognized in this prestigious design award win.”

For more information see the GOOD DESIGN® Award winners webpage.